Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 6C pseudogene 17 (COX6CP17) is a noncoding pseudogene located in the human genome[1]. By definition, pseudogenes like COX6CP17 are genomic DNA sequences similar to functional genes but typically lack protein-coding function due to mutations or truncations. Current scientific evidence indicates that some pseudogenes can participate in the regulation of their parent genes by mechanisms such as serving as competing endogenous RNAs (ceRNAs), acting as siRNA precursors, or modulating mRNA stability, with possible implications in disease biology[2]. However, there is no direct evidence or recognized therapeutic relevance for COX6CP17 specifically, and it is not considered a target for drugs or biological therapies[1][2].
Not applicable; drugs do not target COX6CP17
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 6C pseudogene 17 (COX6CP17).